Table 1.
Study Title | Number of subjects analyzed |
Sequencing or Genotyping Approach |
Purpose of sequencing or genotyping |
Reference for original study |
---|---|---|---|---|
Liver Bank | 43 | CYP2A6-Specific sequencing | Exploratory sequencing | Tanner, Prasad [17] |
Pharmacokinetic Study | 57 | CYP2A6-Specific sequencing | Exploratory sequencing | Mwenifumbo, Sellers [24] |
KIS2 | 26 | CYP2A6-Specific sequencing | Exploratory sequencing | Ho, Mwenifumbo [25] |
KIS3 | 86 | CYP2A6-Specific sequencing | Exploratory sequencing | Cox, Nollen [26] |
Liver Bank | 327 | PGRN-Sequencing, and TaqMan SNP genotyping | Identify SNPs for genotype-phenotype analyses | Tanner, Prasad [17] |
PNAT | 641 | Genotyped via GWAS SNP calls | Identify SNPs for genotype-phenotype analyses | Lerman, Schnoll [7] |